SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001741830-23-000015
Filing Date
2023-03-27
Accepted
2023-03-27 17:20:25
Documents
13
Period of Report
2023-03-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K kron-20230322.htm   iXBRL 8-K 26169
  Complete submission text file 0001741830-23-000015.txt   171198

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20230322.xsd EX-101.SCH 2178
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kron-20230322_def.xml EX-101.DEF 2941
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20230322_lab.xml EX-101.LAB 28000
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20230322_pre.xml EX-101.PRE 15357
7 EXTRACTED XBRL INSTANCE DOCUMENT kron-20230322_htm.xml XML 4430
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 23765467
SIC: 2834 Pharmaceutical Preparations